1. Home
  2. ESPR vs TRVG Comparison

ESPR vs TRVG Comparison

Compare ESPR & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.04

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.78

Market Cap

211.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
TRVG
Founded
2008
2005
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
211.2M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
ESPR
TRVG
Price
$2.04
$2.78
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$8.75
$4.09
AVG Volume (30 Days)
6.5M
26.7K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
N/A
$15.59
Revenue Next Year
$12.81
$8.42
P/E Ratio
N/A
$16.98
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$2.59
52 Week High
$4.18
$5.83

Technical Indicators

Market Signals
Indicator
ESPR
TRVG
Relative Strength Index (RSI) 32.79 47.34
Support Level $1.02 $2.74
Resistance Level $2.08 $3.22
Average True Range (ATR) 0.20 0.10
MACD -0.03 0.00
Stochastic Oscillator 1.14 43.24

Price Performance

Historical Comparison
ESPR
TRVG

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

Share on Social Networks: